Ngumah Quintus C, Buchthal Steven D, Dacheux Ramon F
Department of Ophthalmology, DB-107, University of Alabama at Birmingham, 700 18th Street South, Birmingham, AL 35294, USA.
Exp Eye Res. 2006 Aug;83(2):390-400. doi: 10.1016/j.exer.2006.01.015. Epub 2006 Apr 24.
To determine whether vitreous lactate concentrations are correlated with intraocular pressure (IOP) rise, retinal ganglion cell (RGC) damage, and nerve fiber layer (NFL) thickness decrease in a rabbit model of ocular hypertension. Also, to learn whether proton nuclear magnetic resonance ((1)H-NMR) spectroscopy can provide sequential, non-invasive in vivo measurements of vitreous lactate. Intra-anterior chamber injections of 20-mum latex beads were used to impede aqueous drainage in New Zealand White rabbits, causing an elevation of IOP. Group I consisted of 12 rabbits in which unilateral elevations in IOP were achieved. Group II consisted of 6 rabbits in which treatment did not cause a change in IOP. The contralateral eye served as a control in both groups. Control eyes received an equal volume injection of vehicle only. IOP was measured for two pre-treatment days and then on post-treatment days 1, 3, 5, 7, 9, 16, 23, 30, and 37. (1)H-NMR spectroscopy was used to measure changes in vitreous lactate concentrations that may be associated with the onset and progression of the pathophysiology. Post-mortem histochemical analysis at the light microscope level was used to quantify changes in the retinal NFL thickness and in the numbers of RGC, and correlate them with IOP and percent change in lactate levels. Baseline IOP in Group I control and treated eyes were 12.0+/-1.9 and 12.5+/-1.3 mmHg, respectively. Between days 5 and 9 post-treatment, the IOP in Group I treated eyes (n=12) rose to 23.9+/-4.2 mmHg. IOP in the control eyes remained unchanged (12.0+/-1.6). Vitreous lactate levels in Group I treated eyes increased by 100%, from pre-treatment values. Levels in control eyes remained unchanged. In Group I, IOP and percent change in lactate concentration in treated eyes were closely correlated throughout the study period (r=0.95; p< or =0.05). Group II control and treated eyes showed no significant changes in either IOP or lactate. Group I treated eyes had a reduced NFL thickness (65+/- 4 microm; n=5) at the temporal medullary ray (MR) compared with control eyes (45+/-6 microm). A smaller reduction was found in the nasal MR areas, where thickness was 53+/-3 microm in treated eyes and 66+/-4 microm in control eyes. RGC numbers also were decreased in the treated eyes (241,222+/-10,920 cells) vs. 322,311+/-8726 cells in control eyes. TdT-mediated dUTP nick-end labeling (TUNEL) indicated that RGC loss in the treated eyes was most likely due to apoptosis. In vivo changes in lactate can be monitored non-invasively over time using (1)H-NMR spectroscopy. Vitreous lactate concentrations increased and returned to baseline concurrently with IOP. The brief elevation in IOP produced a reduction in both the RGC cell numbers and in the thickness of the NFL.
在高眼压兔模型中,确定玻璃体液乳酸浓度是否与眼压升高、视网膜神经节细胞(RGC)损伤及神经纤维层(NFL)厚度降低相关。此外,了解质子核磁共振((1)H-NMR)光谱是否能对玻璃体液乳酸进行连续、无创的体内测量。通过向新西兰白兔前房内注射20微米的乳胶珠来阻碍房水引流,从而使眼压升高。第一组由12只实现单侧眼压升高的兔子组成。第二组由6只眼压未发生变化的兔子组成。两组中对侧眼均作为对照。对照眼仅注射等量的赋形剂。在治疗前2天测量眼压,然后在治疗后第1、3、5、7、9、16、23、30和37天测量眼压。使用(1)H-NMR光谱测量可能与病理生理学的发生和发展相关的玻璃体液乳酸浓度变化。在光镜水平进行死后组织化学分析,以量化视网膜NFL厚度和RGC数量的变化,并将它们与眼压及乳酸水平的变化百分比相关联。第一组对照眼和治疗眼的基线眼压分别为12.0±1.9和12.5±1.3 mmHg。在治疗后第5至9天之间,第一组治疗眼(n = 12)的眼压升至23.9±4.2 mmHg。对照眼的眼压保持不变(12.0±1.6)。第一组治疗眼的玻璃体液乳酸水平较治疗前值增加了100%。对照眼的水平保持不变。在第一组中,在整个研究期间,治疗眼的眼压与乳酸浓度变化百分比密切相关(r = 0.95;p≤0.05)。第二组对照眼和治疗眼的眼压或乳酸均无显著变化。与对照眼(45±6微米)相比,第一组治疗眼在颞侧髓射线(MR)处的NFL厚度减小(65±4微米;n = 5)。在鼻侧MR区域发现减小幅度较小,治疗眼的厚度为53±3微米,对照眼为66±4微米。治疗眼中的RGC数量也较对照眼(322,311±8726个细胞)减少(241,222±10,920个细胞)。TdT介导的dUTP缺口末端标记(TUNEL)表明,治疗眼中RGC的损失很可能是由于凋亡。使用(1)H-NMR光谱可随时间对乳酸的体内变化进行无创监测。玻璃体液乳酸浓度随眼压升高而增加,并同时恢复至基线水平。眼压的短暂升高导致RGC细胞数量和NFL厚度均减小。